Has Lori Gerard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,206 in general payments to Lori Gerard, MD across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lori Gerard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lori Gerard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lori Gerard, MD

Endocrinology, Diabetes & Metabolism · Englewood, CONPI 1720134331

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,050 of the $8,206 with a category attached, or 61.5%. Tandem Diabetes Care, Inc. accounts for 62.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $5,209 and has fallen 87.6% since, to $647 in 2025.

$8,206in general payments, 2019–2025

Across 58 payments — averaging $141.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tandem Diabetes Care, Inc.$5K
Eli Lilly$2K
Sanofi-aventis U.S. LLC$648
Insulet Corporation$150
AstraZeneca$135
BETA Bionics, Inc.$118
plus $57 from 1 others

$777,634in research payments, 2019–2025

Across 125 payments — averaging $6221.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Senseonics, Incorporated$329K
Novo Nordisk AS$153K
Sanofi US Services Inc.$128K
Eli Lilly$75K
Biogen$56K
AstraZeneca$36K

What the payments were for

Speaking & faculty fees$5,05062%
Travel & lodging$1,75221%
Food & beverage$1,40517%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tandem Diabetes Care, Inc.	21	$5,140
Eli Lilly	23	$1,959
Sanofi-aventis U.S. LLC	10	$648
Insulet Corporation	1	$150
AstraZeneca	1	$135
BETA Bionics, Inc.	1	$118
Medtronic	1	$57

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

t:slim X2 insulin pump$3,250
t-slim insulin pump$1,800
iLet Bionic Pancreas$353
TZIELD$241
Omnipod$150
Strensiq$135
iLet Insulin Infusion Kit Inset$118
iLet Insulin Infusion Kit Contact Detach$118

How this compares

$8,206 in reported general payments places this provider in the 75th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.

See all endocrinology, diabetes & metabolism providers in Colorado →

Medicare billing

Part B allowed, 2024

$99,061

Medicare patients

352

Services billed

1,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	106	$100,850
MounjaroTirzepatide	79	$96,038
OzempicSemaglutide	57	$93,898
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7	16	$23,107
SynthroidLevothyroxine Sodium	183	$16,821
TrulicityDulaglutide	15	$16,308
Tresiba Flextouch U-200Insulin Degludec	17	$15,422
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	13	$14,373
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	44	$14,299
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	54	$6,719
Novolog FlexpenInsulin Aspart	22	$6,229
HumalogInsulin Lispro	19	$5,992
Humalog Kwikpen U-100Insulin Lispro	16	$3,316
Testosterone	19	$2,225
Levothyroxine Sodium	199	$1,499

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Englewood

Linda BuckleyEnglewood$5K
Kelsi DeaverEnglewood$2K
Rebecca JohnEnglewood$1K
Leigh PerreaultBoulder$1.7M
Satish GargAurora$347K
Viralkumar ShahAurora$256K
Neda RasouliAurora$188K
Michelle CassaraArvada$141K
Halis AkturkAurora$109K
Irinel StanciuArvada$104K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →